These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 12036390)

  • 1. Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?
    Mourad M; Wallemacq P; König J; de Frahan EH; Eddour DC; De Meyer M; Malaise J; Squifflet JP
    Clin Pharmacokinet; 2002; 41(5):319-27. PubMed ID: 12036390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring of mycophenolate mofetil in transplantation.
    van Gelder T; Le Meur Y; Shaw LM; Oellerich M; DeNofrio D; Holt C; Holt DW; Kaplan B; Kuypers D; Meiser B; Toenshoff B; Mamelok RD
    Ther Drug Monit; 2006 Apr; 28(2):145-54. PubMed ID: 16628123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.
    del Mar Fernández De Gatta M; Santos-Buelga D; Domínguez-Gil A; García MJ
    Clin Pharmacokinet; 2002; 41(2):115-35. PubMed ID: 11888332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
    Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic monitoring of mycophenolate mofetil.
    Jeong H; Kaplan B
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):184-91. PubMed ID: 17699403
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycophenolic acid trough level monitoring in solid organ transplant recipients treated with mycophenolate mofetil: association with clinical outcome.
    Kaplan B
    Curr Med Res Opin; 2006 Dec; 22(12):2355-64. PubMed ID: 17257450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring of mycophenolic acid in solid organ transplant patients treated with mycophenolate mofetil: review of the literature.
    Arns W; Cibrik DM; Walker RG; Mourad G; Budde K; Mueller EA; Vincenti F
    Transplantation; 2006 Oct; 82(8):1004-12. PubMed ID: 17060847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation.
    Tönshoff B; David-Neto E; Ettenger R; Filler G; van Gelder T; Goebel J; Kuypers DR; Tsai E; Vinks AA; Weber LT; Zimmerhackl LB
    Transplant Rev (Orlando); 2011 Apr; 25(2):78-89. PubMed ID: 21454065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive drugs in paediatric liver transplantation.
    van Mourik ID; Kelly DA
    Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection.
    Nicholls AJ
    Clin Biochem; 1998 Jul; 31(5):329-33. PubMed ID: 9721430
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients.
    Shaw LM; Korecka M; DeNofrio D; Brayman KL
    Clin Biochem; 2001 Feb; 34(1):17-22. PubMed ID: 11239510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualization of mycophenolate mofetil dose in renal transplant recipients.
    van Hest RM; Hesselink DA; Vulto AG; Mathot RA; van Gelder T
    Expert Opin Pharmacother; 2006 Mar; 7(4):361-76. PubMed ID: 16503809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.
    Staatz CE; Tett SE
    Arch Toxicol; 2014 Jul; 88(7):1351-89. PubMed ID: 24792322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical assessment of mycophenolate drug monitoring after liver transplantation.
    Hwang S; Lee SG; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Choi NK; Kim KW; Yu YD; Park GC; Park PJ; Choi YI
    Clin Transplant; 2010; 24(2):E35-42. PubMed ID: 20070319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which is more suitable for kidney transplantation at the early post-transplantation phase in China - low dosing or standard dosing of enteric-coated mycophenolate sodium?
    Ding C; Xue W; Tian P; Ding X; Pan X; Xiang H; Tian X; Li Y; Zheng J
    Int J Clin Pract Suppl; 2014 Apr; (181):10-6. PubMed ID: 24673714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of therapeutic drug monitoring of MMF therapy in pediatric transplantation.
    Filler G
    Pediatr Transplant; 2006 Sep; 10(6):707-11. PubMed ID: 16911495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic drug monitoring of mycophenolate mofetil, sirolimus and cyclosporine at C2].
    Royer B; Davani S; Bérard M; Kantelip JP; Muret P
    Ann Biol Clin (Paris); 2003; 61(3):251-8. PubMed ID: 12805001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining algorithms for efficient therapeutic drug monitoring of mycophenolate mofetil in heart transplant recipients.
    Kaczmarek I; Bigdeli AK; Vogeser M; Mueller T; Beiras-Fernandez A; Kaczmarek P; Schmoeckel M; Meiser B; Reichart B; Ueberfuhr P
    Ther Drug Monit; 2008 Aug; 30(4):419-27. PubMed ID: 18641552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolic mofetil optimized pharmacokinetic modelling, and exposure-effect associations in adult heart transplant recipients.
    Woillard JB; Saint-Marcoux F; Monchaud C; Youdarène R; Pouche L; Marquet P
    Pharmacol Res; 2015 Sep; 99():308-15. PubMed ID: 26192348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
    Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
    J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.